
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Factor Therapeutics Limited is a biotechnology business based in Australia. Factor Therapeutics shares (FTT) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Factor Therapeutics has a trailing 12-month revenue of around $665,817..
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $0.001 - $0.007 |
---|---|
50-day moving average | $0.005 |
200-day moving average | $0.0041 |
Target price | $0.01 |
PE ratio | 25 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $0.002 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$0.005 on 2020-10-22
1 week (2021-01-15) | 0% |
---|---|
1 month (2020-12-23) | 0% |
3 months (2020-10-23) | 0% |
6 months (2020-07-23) | 0% |
1 year (2020-01-23) | 66.67% |
---|---|
2 years (2019-01-23) | 100.00% |
3 years (2018-01-23) | -88.26% |
5 years (2016-01-22) | -86.91% |
Valuing Factor Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Factor Therapeutics 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Factor Therapeutics 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, Factor Therapeutics shares trade at around 25x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Factor Therapeutics 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $250,468 (£141,402).
The EBITDA is a measure of a Factor Therapeutics 's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $665,817 |
---|---|
Operating margin TTM | 37.29% |
Gross profit TTM | $2.4 million |
Return on assets TTM | 4.39% |
Return on equity TTM | 8.01% |
Profit margin | 40.59% |
Book value | 0.003 |
Market capitalisation | $5.2 million |
TTM: trailing 12 months
We're not expecting Factor Therapeutics to pay a dividend over the next 12 months.
Factor Therapeutics 's shares were split on 4 February 2009.
Over the last 12 months, Factor Therapeutics 's shares have ranged in value from as little as $0.001 up to $0.007. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Factor Therapeutics 's is 0.811. This would suggest that Factor Therapeutics 's shares are less volatile than average (for this exchange).
Factor Therapeutics Limited operates as a clinical stage biotechnology company. The company was formerly known as Tissue Therapies Limited and changed its name to Factor Therapeutics Limited in May 2016. Factor Therapeutics Limited is based in Brisbane, Australia.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.